US 12006516
Differentiation of pancreatic endocrine cells
granted A61KA61K35/39
Quick answer
US patent 12006516 (Differentiation of pancreatic endocrine cells) held by Vertex Pharmaceuticals Incorporated expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jun 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K35/39